- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2008-001395-74.
Displaying page 1 of 1.
EudraCT Number: 2008-001395-74 | Sponsor Protocol Number: MER-101-03 | Start Date*: 2008-06-30 | |||||||||||
Sponsor Name:Merrion Pharmaceuticals plc | |||||||||||||
Full Title: A multi-center Phase II study to compare MER-101 20mg tablets to intravenous Zometa® 4mg in male bisphosphonate-naïve, hormone-refractory prostate cancer patients | |||||||||||||
Medical condition: Hormone - refractory prostate cancer with bone metastases and no prior bisphoshonate treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: EE (Completed) LV (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
